Figure 2
From: Identification of EMT-associated prognostic features among grade II/III gliomas
Comparative analysis of clinical features, immune subtypes, and survival outcomes in two molecular subtypes of grade II/III gliomas from TCGA dataset. (A–C) Compares the distribution of two molecular subtypes in different clinical features in the TCGA dataset. (D) Comparison of the distribution of molecular immune subtypes in the two subtypes. (E) Compares the distribution of immune subtypes in different clinical features in the TCGA dataset. (F) Comparison of the two subtypes with existing molecular immune subtypes. (G,H) KM curves of OS time and DFS time among different immune subtypes.
